Objectives. To analyze polymorphic loci of genes whose products are directly involved in the molecular mechanisms regulating neurophysiological processes. Materials and methods. The cohort of subjects consisted of 128 unrelated males and females living in the European part of Russia. The study evaluated the frequencies of occurrence of 11 single-nucleotide substitutions located in the genes encoding serotonin receptors, ciliary neurotrophic factor, uncoupling protein 2, methylenetetrahydrofolate reductase, methionine synthase, methionine synthase reductase, dipeptidylcarboxypeptidase 1, peroxisome proliferator-activated receptor γ-coactivator, and brain-derived neurotrophic factor. Genotyping of samples was by PCR with fluorescent detection and restriction fragment length polymorphism analysis. Results. The distributions of genotype polymorphisms complied with Hardy–Weinberg equilibrium, with the exception of rs1801133 MTHFR (χ2 = 5.3088, p = 0.0212), where there was a reduced level of heterozygosity. Study data on the distributions of minor alleles did not show statistically significant deviations from data obtained from the European population, though there were deviations with respect to the Asian, African, and Latin American populations. Conclusions. Statistically significant consistency of allele frequencies in the study group with populations from other regions and studies run in them provide grounds for including the single-nucleotide polymorphisms selected here in a list of a limited set of molecular genetic markers, which can supplement the mental health monitoring system and improve the professional training of people in extreme professions.
Similar content being viewed by others
References
M. Spies, A. Nasser, B. Ozenne, et al., “Common HTR2A variants and 5-HTTLPR are not associated with human in vivo serotonin 2A receptor levels, Hum. Brain Mapp., 16, XLI, 4518–4528 (2020), https://doi.org/10.1002/hbm.25138.
N. Brondino, M. Rocchetti, L. Fusar-Poli, et al., “Increased CNTF levels in adults with autism spectrum disorders,” World J. Biol. Psychiatry, 20, No. 9, 742–746 (2019), https://doi.org/10.1080/15622975.2018.1481999.
S. Ramaswamy and J. H. Kordower, “Gene therapy for Huntington’s disease,” Neurobiol. Dis., 48, No. 2, 243–254 (2012), https://doi.org/10.1016/j.nbd.2011.12.030.
S. F. Kazim and K. Iqbal, “Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer’s disease,” Mol. Neurodegener., 11, No. 1, 50 (2016), https://doi.org/10.1186/s13024-016-0119-y.
V. Heise, E. Zsoldos, S. Suri, et al., “Uncoupling protein 2 haplotype does not affect human brain structure and function in a sample of community-dwelling older adults,” PLoS One, 12, No. 8, 63–68 (2017), https://doi.org/10.1371/journal.pone.0181392.
M. Donadelli, I. Dando, C. Fiorini, et al., “UCP2, a mitochondrial protein regulated at multiple levels,” Cell. Mol. Life Sci., 71, No. 7, 1171–1190 (2014), https://doi.org/10.1007/s00018-013-1407-0.
S. Cardoso, S. Correia, C. Carvalho, et al., “Perspectives on mitochondrial uncoupling proteins-mediated neuroprotection,” J. Bioenerg. Biomembr., 47, No. 2, 119–131 (2015), https://doi.org/10.1007/s10863-014-9580-x.
L. Wan, Y. Li, Z. Zhang, et al., “Methylenetetrahydrofolate reductase and psychiatric diseases,” Transl. Psychiatry, 8, No. 1, 242 (2018), https://doi.org/10.1038/s41398-018-0276-6.
Z. Zhang, L. Yu, S. Li, et al., “Association study of polymorphisms in genes relevant to vitamin B12 and folate metabolism with childhood autism spectrum disorder in a Han Chinese population,” Med. Sci. Monit., 19, 370–376 (2018), https://doi.org/10.12659/msm.905567.
T. Saha, M. Chatterjee, D. Verma, et al., “Genetic variants of the folate metabolic system and mild hyperhomocysteinemia may affect ADHD associated behavioral problems,” Prog. Neuropsychopharmacol. Biol. Psychiatry, 84, No. 1, 1–10 (2018), https://doi.org/10.1016/j.pnpbp.2018.01.016.
J. L. Roffman, D. G. Brohawn, A. Z. Nitenson, et al., “Genetic variation throughout the folate metabolic pathway influences negative symptom severity in schizophrenia,” Schizophr. Bull., 39, No. 2, 330–338 (2013), https://doi.org/10.1093/schbul/sbr150.
D. S. Froese, T. Huemer, P. Suormala, et al., “Mutation update and review of severe methylenetetrahydrofolate reductase deficiency,” Hum. Mutat., 37, No. 5, 427–438 (2016), https://doi.org/10.1002/humu.22970.
S. Dutta, J. Shaw, A. Chatterjee, et al., “Importance of gene variants and co-factors of folate metabolic pathway in the etiology of idiopathic intellectual disability,” Nutr. Neurosci., 14, No. 5, 202–209 (2011), https://doi.org/10.1179/1476830511Y.0000000016.
S. C. Liew and E. D. Gupta, “Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases,” Eur. J. Med. Genet., 58, 1–10 (2015), https://doi.org/10.1016/j.ejmg.2014.10.004.
E. Dardiotis, S. Arseniou, M. Sokratous, et al., “Vitamin B12, folate, and homocysteine levels and multiple sclerosis: A meta-analysis,” Mult. Scler. Relat. Disord., 17, 190–197 (2017), https://doi.org/10.1016/j.msard.2017.08.004.
F. Coppede, P. Tannorella, I. Pezzini, et al., “Folate, homocysteine, vitamin B12, and polymorphisms of genes participating in one-carbon metabolism in late-onset Alzheimer’s disease patients and healthy controls,” Antioxid. Redox Signal, 17, No. 2, 195–204 (2012), https://doi.org/10.1089/ars.2011.4368.
L. Mandelli and A. Serretti, “Gene environment interaction studies in depression and suicidal behavior: An update,” Neurosci. Biobehav. Rev., 37, No. 10, 2375–2397 (2013), https://doi.org/10.1016/j.neubiorev.2013.07.011.
J. F. Lucatelli, A. C. Barros, V. K. Silva, et al., “Genetic influences on Alzheimer’s disease: evidence of interactions between the genes APOE, APOC1 and ACE in a sample population from the South of Brazil,” Neurochem. Res., 36, No. 8, 1533–1539 (2011), https://doi.org/10.1007/s11064-011-0481-7.
A. Johri and A. Chandra, “PGC-1α, mitochondrial dysfunction, and Huntington’s disease,” Free Radic. Biol. Med., 62, 37–46 (2013), https://doi.org/10.1016/j.freeradbiomed.2013.04.016.
P. A. Geoffroy, B. Etain, and M. Lajnef, “Circadian genes and lithium response in bipolar disorders: associations with PPARGC1A (PGC-1α) and RORA,” Genes Brain Behav., 15, No. 7, 660–668 (2016), https://doi.org/10.1111/gbb.12306.
C. C. Wang and F. W. Lung, “The role of PGC-1 and Apoε4 in insomnia,” Psychiatr. Genet., 22, No. 2, 82–87 (2012), https://doi.org/10.1097/YPG.0b013e32834dc438.
J. Wang, H. R. Song, M. N. Guo, et al., “PGC-1α regulate critical period plasticity via gene environment interaction in the developmental trajectory to schizophrenia,” Biochem. Biophys. Res. Commun., 525, No. 4, 989–996 (2020), https://doi.org/10.1016/j.bbrc.2020.03.030.
Z. G. Kokaeva, T. O. Kochetkova, E. V. Afonchikova, et al., “Studies of brain-derived neurotropic factor (BDNF) gene polymorphism in Moscow residents,” Genetika, 49, No. 12, 1432–1435 (2013), https://doi.org/10.7868/S0016675813120047.
“World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects World Medical Association,” JAMA, 20, 2191–2194 (2013).
National Library of Medicine, National Center for Biotechnology Information (NCBI), https://www.ncbi.nlm.nih.gov/snp/?term=rs.
J. Nishiyama, M. Tochigi, S. Itoh, et al., “No association between the CNTF null mutation and schizophrenia or personality,” Psychiatr. Genet., 16, No. 5, 217–219 (2006), https://doi.org/10.1097/01.ypg.0000242189.05656.9d.
L. Wan, Y. Li, Z. Zhang, et al., “Methylenetetrahydrofolate reductase and psychiatric diseases,” Transl. Psychiatry, 8, No. 1, 1–12 (2018), https://doi.org/10.1038/s41398-018-0276-6.
C. Lavedan, S. Volpi, and M. H. Polymeropoulos, “Effect of a ciliary neurotrophic factor polymorphism on schizophrenia symptom improvement in an iloperidone clinical trial,” Pharmacogenomics, 9, No. 3, 289–301 (2008), https://doi.org/10.2217/14622416.9.3.289.
N. Antypa, R. Calati, and D. Souery, “Variation in the HTR1A and HTR2A genes and social adjustment in depressed patients,” J. Affect. Disord., 150, No. 2, 649–652 (2013), https://doi.org/10.1016/j.jad.2013.02.036.
Y. L. Jian, Y. J. Ming, M. K. Zhou, et al., “Influence of 5-HTR2A genetic polymorphisms on the efficacy of antidepressants in the treatment of major depressive disorder: A meta-analysis,” J. Affect. Disord., 168, 430–438 (2014), https://doi.org/10.1016/j.jad.2014.06.012.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 122, No. 6, Iss. 1, pp. 122–127, June, 2022.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kutelev, G.G., Malyshkin, S.S., Krivoruchko, A.B. et al. Characteristics of Genetic Polymorphisms Associated with Neurophysiological Processes and Analysis of Their Frequency Distributions in the Russian Population. Neurosci Behav Physi 53, 164–169 (2023). https://doi.org/10.1007/s11055-023-01403-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-023-01403-x